Construction of a classification model for liver fibrosis in MAFLD based on multiparametric MRI radiomics and machine

Xing Xia1, Jian He1, Yong Wen1

  • 1Department of Radiology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.

Medical Physics
|May 24, 2026
PubMed
Abstract

Insights

Machine learning and multiparametric MRI radiomics accurately stage liver fibrosis in metabolic dysfunction-associated fatty liver disease (MAFLD) rats. This noninvasive method aids in differentiating advanced fibrosis, supporting clinical decisions for MAFLD patients.

Area of Science:

  • Radiology
  • Machine Learning
  • Hepatology

Background:

  • Liver fibrosis (LF) severity is crucial for managing metabolic dysfunction-associated fatty liver disease (MAFLD).
  • Current imaging and clinical methods lack precision for accurate LF staging.
  • Multiparametric magnetic resonance imaging (mpMRI) offers a noninvasive, quantitative approach for fibrosis assessment.

Purpose of the Study:

  • To develop and validate a machine learning (ML) model for LF staging in MAFLD using mpMRI radiomics.
  • To assess the model's diagnostic performance in a rat model.

Main Methods:

  • 160 male Sprague-Dawley rats with varying LF severity underwent mpMRI (T2-FS, IDEAL-IQ).
  • Radiomic features were extracted and screened; ML classifiers (LR, DT, SVM, RF, LightGBM, AdaBoost) were trained and validated.
  • Three models (conventional, deep learning, hybrid) were constructed and evaluated using AUC, DCA, NRI, and calibration curves.

Main Results:

  • All developed models demonstrated good diagnostic performance for LF staging in MAFLD, outperforming a CNN model.
  • The hybrid model achieved the highest AUC (0.982) for distinguishing advanced from non-advanced fibrosis with 88% accuracy.
  • SHAP analysis revealed deep learning features significantly contributed to predictions, correlating with MASH and fibrosis progression risk.

Conclusions:

  • mpMRI-based radiomics combined with ML shows promise for noninvasively classifying MASH and staging LF in MAFLD.
  • This approach can help differentiate advanced from non-advanced fibrosis in MASH.
  • The findings have potential to support clinical decision-making in MAFLD management.

Related Concept Videos